Mary Vickery

Mary Vickery has a diverse work experience in the field of quality assurance, specifically in the area of Good Clinical Practice (GCP) QA. Mary most recently worked as a Director of GCP QA at Leap Therapeutics starting in May 2023. Prior to that, they held similar roles as a Director of GCP QA at Curis from July 2022 to May 2023, and as an Associate Director of GCP Quality Assurance at Scholar Rock from June 2020 to July 2022. Before focusing on GCP QA, they gained experience in clinical QA as a Senior Manager at Deciphera Pharmaceuticals from May 2019 to May 2020 and as a Senior Manager of GCP QA at TESARO, Inc. from September 2018 to April 2019. Mary also has experience as a Senior GCP Quality Manager at Alnylam Pharmaceuticals from December 2017 to August 2018. Mary started their career in the pharmaceutical industry as a Manager of GCP Compliance at Agios Pharmaceuticals from June 2016 to December 2017. Prior to that, they worked as a Quality and Process Analyst at Biogen from February 2009 to June 2016. Before joining the industry, Mary worked as a Project Manager at Outcome from March 2008 to November 2008 and as a Project Coordinator at Memorial Sloan-Kettering Cancer Center from August 2006 to February 2008.

From 1999 to 2004, Mary Vickery attended Northeastern University, where they earned a Bachelor of Arts degree in Psychology.